| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |